Vendor, Evanston, IL
SNC Therapeutics, Inc.
UEI YNQPL17KGWA6, CAGE 253M3
2 awards and $6,997,810 obligated between September 24, 2026 and September 30, 2026, 100% under full and open competition, against 2.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 | $3,499,423 |
| Research and Development in NanotechnologyNAICS 541713 | $3,498,387 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition After Exclusion of Sources | 2 |
| Small Business Set Aside - Total | 2 |
| Definitive Contract | 2 |
Hear when SNC Therapeutics, Inc. wins an award and when a contract it holds is about to end.Follow it
Contracts ending soon
None of SNC Therapeutics, Inc.'s contracts with a published end date ends in the next 19 months.
Competes with
Vendors selling research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology) to Departmental Offices, by dollars.
| Global Secure Shipping Inc.Old Town, ME | $12,676,526 |
| Boundless Science Inc.Chapel Hill, NC | $6,900,833 |
| Rydberg Technologies Inc.Ann Arbor, MI | $6,300,496 |
| Zigguratum, Inc.Chattanooga, TN | $5,851,904 |
| Hypercomp Inc.Thousand Oaks, CA | $5,292,228 |
| Nirsense, Inc.Richmond, VA | $5,050,000 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 140D0426C0123Definitive Contract, September 24, 2026, Full and Open Competition After Exclusion of Sources, 2 offers | Ibc Acq SVCS DirectorateDepartmental Offices | Arpa-H SNC Quiet STTR Phase IINAICS 541715, PSC AN13 | $3,499,423 |
| 140D0426C0122Definitive Contract, September 24, 2026, Full and Open Competition After Exclusion of Sources, 2 offers | Ibc Acq SVCS DirectorateDepartmental Offices | Arpa-H SNC Shield STTR Phase IINAICS 541713, PSC AN13 | $3,498,387 |
- Places of performance
- Illinois
- Product and service codes
- AN13 Health R&D Services; Health Care Services; Experimental Development
- Transactions
- 3 across 2 awards